Taken together, these results demonstrated that the NORAD/miR-224-3p/MTDH axis promoted nuclear accumulation of β-catenin to activate this protein, and thus contributed to CDDP resistance and progression in ESCC cells. Here, NORAD is linked to esophageal squamous cell carcinoma.